Jul 2026
LncRNA DLX6-AS1 Regulates the Pathological Process Related to Alzheimer’s Disease via miR-204-5p
Serum DLX6-AS1 is a potential biomarker for early diagnosis and assessment of AD, and regulates Aβ-induced neuronal damage and tau phosphorylation by targeting miR-204-5p, offering a new mechanism target for AD molecular therapy.
Minggang Jiang, Yang Lin, Liping Wang et al.
· Neuromolecular medicine · 0 citations